Biological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum

We sought to develop estimates of biological variation (BV) for 9 enzymes in blood serum as part of the European Biological Variation Study. Ninety-one healthy study participants (38 male and 53 female, 21-69 years old) were phlebotomized in each of 10 consecutive weeks at 6 European laboratories. T...

Full description

Saved in:
Bibliographic Details
Published inClinical Chemistry Vol. 63; no. 6; pp. 1141 - 1150
Main Authors Carobene, Anna, Roraas, Thomas, Solvik, Una Orvim, Sylte, Marit Sverresdotter, Sandberg, Sverre, Guerra, Elena, Marino, Irene, Jonker, Niels, Barla, Gerhard, Bartlett, William A., Fernandez-Calle, Pilar, Diaz-Garzon, Jorge, Tosato, Francesca, Plebani, Mario, Coskun, Abdurrahman, Serteser, Mustafa, Unsal, Ibrahim, Ceriottil, Ferruccio, Biological, E.F.L.M. Working Grp
Format Journal Article
LanguageEnglish
Published England Oxford University Press (OUP) 01.06.2017
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We sought to develop estimates of biological variation (BV) for 9 enzymes in blood serum as part of the European Biological Variation Study. Ninety-one healthy study participants (38 male and 53 female, 21-69 years old) were phlebotomized in each of 10 consecutive weeks at 6 European laboratories. The same preanalytical sample-handling protocol was followed at each center before transport to San Raffaele Hospital, Milan, Italy, for analysis. Sera were stored at -80 °C before analysis in duplicate within a single run on an ADVIA 2400 Clinical Chemistry System (Siemens Healthcare) following a protocol designed to minimize analytical imprecision. Assay traceability was established using frozen sera with target values assigned by reference methods. The results were subjected to outlier analysis before CV-ANOVA to deliver valid BV estimates. Results for 9 enzymes were subsequently partitioned for graphical display allowing visual assessment of the effects of country of origin, sex, and age on BV estimates. We found no effect of country upon the observed variation, but overall sex-related differences were evident for alanine amino transferase (ALT), γ-glutamyl transferase (GGT), and creatine kinase (CK). The following estimates for within-subject BV (CV ) and between-subject BV (CV ), respectively, were obtained: ALT: 9.3%, 28.2%; aspartate aminotransferase: 9.5%, 20.3%; GGT: 8.9%, 41.7%; alkaline phosphatase : 5.3%, 24.9%; lactate dehydrogenase: 5.2%, 12.6%; CK: 14.5%, 31.5%; amylase: 6.8%, 30.4%; pancreatic α-amylase: 6.3%, 24.9%; and lipase (LIP): 7.7%, 23.8%. All CV and some CV estimates were lower than those reported in the online BV 2014 updated database. Analytical performance specifications derived from BV can be applied internationally.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0009-9147
1530-8561
1530-8561
DOI:10.1373/clinchem.2016.269811